Skip to main content
Clinical Trials/JPRN-UMIN000036062
JPRN-UMIN000036062
Recruiting
未知

Controlled study for evaluation of the effect of AHCC(R) intake on eradication of high-risk type Human papillomavirus infection - A study for evaluation of AHCC(R) on eradication of Human papillomavirus

Hokkaido University Hospital0 sites180 target enrollmentMarch 1, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
High-risk type Human papillomavirus (HPV) infection
Sponsor
Hokkaido University Hospital
Enrollment
180
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2019
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (a) Women diagnosed as having a histological diagnosis of Cervical Intraepithelial Neoplasia (CIN) grade 3 or worse, or who are in need of medical treatment (b) Women taking immuno suppressors such as steroids or biologics such as TNF\-alpha (c) Women regularly taking immunostimulating supplements (d) Women with an uncontrolled progressive malignancy (e) Women suffering from any mental illness or mental symptoms which would make it difficult for them to participate in the study (f) Women who are unable to return for follow\-up appointments. (g) Women who are or may be pregnant (h) Women who, for any other reason, are considered not suitable for participation by the investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials